US 8829030
Compounds and methods for the treatment or prevention of Flavivirus infections
granted A61KA61K31/381A61K31/4535
Quick answer
US patent 8829030 (Compounds and methods for the treatment or prevention of Flavivirus infections) held by Vertex Pharmaceuticals (Canada) Incorporated expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals (Canada) Incorporated
- Grant date
- Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/381, A61K31/4535, A61K31/55, A61K45/00